More Impact（AEE1）株式概要モア・インパクトAGは、再生可能エネルギー、栄養、ヘルスケア、電化産業の創造と資本市場に焦点を当てている。 詳細AEE1 ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績0/6財務の健全性0/6配当金0/6リスク分析過去1年間で株主の希薄化は大幅に進んだ 財務データは報告されていない German市場と比較した過去 3 か月間の株価の変動すべてのリスクチェックを見るAEE1 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€0.91該当なし内在価値ディスカウントEst. Revenue$PastFuture012016201920222025202620282031Revenue €1.0Earnings €0.3AdvancedSet Fair ValueView all narrativesMore Impact AG 競合他社Ernst RussSymbol: XTRA:ERAGMarket cap: €268.2mOVB HoldingSymbol: XTRA:O4BMarket cap: €287.9mDeutsche BalatonSymbol: HMSE:BBHKMarket cap: €296.5mMPC Münchmeyer Petersen CapitalSymbol: XTRA:MPCKMarket cap: €184.7m価格と性能株価の高値、安値、推移の概要More Impact過去の株価現在の株価€0.9152週高値€2.2052週安値€0.69ベータ01ヶ月の変化1.11%3ヶ月変化-20.87%1年変化-49.44%3年間の変化89.58%5年間の変化n/aIPOからの変化-98.96%最新ニュースお知らせ • Jun 26More Impact AG, Annual General Meeting, Aug 04, 2026More Impact AG, Annual General Meeting, Aug 04, 2026, at 11:00 W. Europe Standard Time.New Risk • Dec 03New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (12% average weekly change). Shareholders have been substantially diluted in the past year (346% increase in shares outstanding).お知らせ • Jul 15More Impact AG, Annual General Meeting, Aug 21, 2025More Impact AG, Annual General Meeting, Aug 21, 2025, at 11:00 W. Europe Standard Time.お知らせ • Jul 02More Impact AG Announces Supervisory Board ChangesMore Impact AG announced that the Frankfurt District Court has appointed Prof. Dr. Stefan Hegemann as a new member of the Supervisory Board following a proposal by the company. He succeeds Dr. Karsten Behlke, who has resigned from office to move to the operational business of More Impact AG. Prof. Hegemann will stand for election to the Supervisory Board at the company's upcoming Ordinary General Meeting on August 21, 2025. With his long-standing experience as a medical doctor and his comprehensive scientific know-how, Prof. Hegemann will support More Impact in its future growth. He is a honorary professor of the University of Zurich and is also the founder of the renowned "Balance Clinic". Prof. Hegemann was head physician at the Department of Otorhinolaryngology and Facial Surgery of the University Hospital Zurich for several years. He also worked at the Johns Hopkins University in Baltimore and the Karlsbad-Langensteinbach Clinic. He completed his medical studies at the University of Essen, the LMU Munich, the McMaster University Hamilton and the University of Cape Town in South Africa. Prof. Hegemann is a member of the Prosper Menière Society, the Association of German-speaking Audiologists and Neurootologists (ADANO) and the Robert Barány Society. He is also a member of both the German Society for ENT and Neurology, Head and Neck Surgery and the Swiss Society for Otorhinolaryngology, Neck and Facial Surgery. In addition, he has been honoured with several accolades, including the ADANO Innovation Award.New Risk • Apr 29New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €85.8m (US$97.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (14% average weekly change). Shareholders have been substantially diluted in the past year (over 8x increase in shares outstanding). Minor Risk Market cap is less than US$100m (€85.8m market cap, or US$97.9m).お知らせ • Apr 10More Impact AG and BG Braingate Technology GmbH Introduces Z-Boxx as an Innovative Smoking Cessation ProductMore Impact AG and its wholly owned subsidiary BG Braingate Technology GmbH are launching the Z-Boxx. Braingate is thus integrating its patented inhaler technology into a marketable product. The Z-Boxx allows smokers to gradually quit nicotine without having to give up the smoking experience. The Z-Boxx thus makes an active contribution to improving health and also significantly reduces the burden on the environment by avoiding waste. The comprehensive market launch of the innovative product is planned for the fourth quarter of 2025. The Z-Boxx is based on an innovative, patented filter and vaporization technology that heats tobacco instead of burning it. The actual nicotine dosage can be regulated so that the Z-Boxx can be used to continuously reduce the smoker’s nicotine intake – right up to complete nicotine abstinence. In addition, no typical combustion products such as tar or carbon monoxide are produced. The mechanism of action of the Z-Boxx therefore directly addresses the most harmful aspects of smoking. Nevertheless, the smoking experience remains authentic in taste. Compared to disposable e-cigarettes or traditional tobacco products, the Z-Boxx produces no environmentally harmful filter waste, as filterless cigarettes are used and harmful substances are filtered out. According to the WHO, an estimated 4.5 trillion cigarette filters end up in the environment worldwide every year. The battery of the Z-Boxx can also be flexibly removed and recharged, which significantly reduces electronic waste.最新情報をもっと見るRecent updatesお知らせ • Jun 26More Impact AG, Annual General Meeting, Aug 04, 2026More Impact AG, Annual General Meeting, Aug 04, 2026, at 11:00 W. Europe Standard Time.New Risk • Dec 03New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (12% average weekly change). Shareholders have been substantially diluted in the past year (346% increase in shares outstanding).お知らせ • Jul 15More Impact AG, Annual General Meeting, Aug 21, 2025More Impact AG, Annual General Meeting, Aug 21, 2025, at 11:00 W. Europe Standard Time.お知らせ • Jul 02More Impact AG Announces Supervisory Board ChangesMore Impact AG announced that the Frankfurt District Court has appointed Prof. Dr. Stefan Hegemann as a new member of the Supervisory Board following a proposal by the company. He succeeds Dr. Karsten Behlke, who has resigned from office to move to the operational business of More Impact AG. Prof. Hegemann will stand for election to the Supervisory Board at the company's upcoming Ordinary General Meeting on August 21, 2025. With his long-standing experience as a medical doctor and his comprehensive scientific know-how, Prof. Hegemann will support More Impact in its future growth. He is a honorary professor of the University of Zurich and is also the founder of the renowned "Balance Clinic". Prof. Hegemann was head physician at the Department of Otorhinolaryngology and Facial Surgery of the University Hospital Zurich for several years. He also worked at the Johns Hopkins University in Baltimore and the Karlsbad-Langensteinbach Clinic. He completed his medical studies at the University of Essen, the LMU Munich, the McMaster University Hamilton and the University of Cape Town in South Africa. Prof. Hegemann is a member of the Prosper Menière Society, the Association of German-speaking Audiologists and Neurootologists (ADANO) and the Robert Barány Society. He is also a member of both the German Society for ENT and Neurology, Head and Neck Surgery and the Swiss Society for Otorhinolaryngology, Neck and Facial Surgery. In addition, he has been honoured with several accolades, including the ADANO Innovation Award.New Risk • Apr 29New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €85.8m (US$97.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (14% average weekly change). Shareholders have been substantially diluted in the past year (over 8x increase in shares outstanding). Minor Risk Market cap is less than US$100m (€85.8m market cap, or US$97.9m).お知らせ • Apr 10More Impact AG and BG Braingate Technology GmbH Introduces Z-Boxx as an Innovative Smoking Cessation ProductMore Impact AG and its wholly owned subsidiary BG Braingate Technology GmbH are launching the Z-Boxx. Braingate is thus integrating its patented inhaler technology into a marketable product. The Z-Boxx allows smokers to gradually quit nicotine without having to give up the smoking experience. The Z-Boxx thus makes an active contribution to improving health and also significantly reduces the burden on the environment by avoiding waste. The comprehensive market launch of the innovative product is planned for the fourth quarter of 2025. The Z-Boxx is based on an innovative, patented filter and vaporization technology that heats tobacco instead of burning it. The actual nicotine dosage can be regulated so that the Z-Boxx can be used to continuously reduce the smoker’s nicotine intake – right up to complete nicotine abstinence. In addition, no typical combustion products such as tar or carbon monoxide are produced. The mechanism of action of the Z-Boxx therefore directly addresses the most harmful aspects of smoking. Nevertheless, the smoking experience remains authentic in taste. Compared to disposable e-cigarettes or traditional tobacco products, the Z-Boxx produces no environmentally harmful filter waste, as filterless cigarettes are used and harmful substances are filtered out. According to the WHO, an estimated 4.5 trillion cigarette filters end up in the environment worldwide every year. The battery of the Z-Boxx can also be flexibly removed and recharged, which significantly reduces electronic waste.New Risk • Mar 01New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €95.2m (US$98.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (25% average weekly change). Shareholders have been substantially diluted in the past year (over 8x increase in shares outstanding). Minor Risk Market cap is less than US$100m (€95.2m market cap, or US$98.7m).New Risk • Sep 17New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Over 8x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Shareholders have been substantially diluted in the past year (over 8x increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Market cap is less than US$100m (€27.3m market cap, or US$30.4m).New Risk • Aug 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Market cap is less than US$10m (€4.02m market cap, or US$4.40m). Minor Risk Share price has been volatile over the past 3 months (6.8% average weekly change).お知らせ • Jul 23Aee Gold Ag, Annual General Meeting, Aug 29, 2024Aee Gold Ag, Annual General Meeting, Aug 29, 2024, at 11:00 W. Europe Standard Time.株主還元AEE1DE Capital MarketsDE 市場7D0%-2.9%-1.7%1Y-49.4%3.0%-0.6%株主還元を見る業界別リターン: AEE1過去 1 年間で3 % の収益を上げたGerman Capital Markets業界を下回りました。リターン対市場: AEE1は、過去 1 年間で-0.6 % のリターンを上げたGerman市場を下回りました。価格変動Is AEE1's price volatile compared to industry and market?AEE1 volatilityAEE1 Average Weekly Movement10.6%Capital Markets Industry Average Movement4.3%Market Average Movement5.7%10% most volatile stocks in DE Market13.4%10% least volatile stocks in DE Market2.8%安定した株価: AEE1の株価は、 German市場と比較して過去 3 か月間で変動しています。時間の経過による変動: AEE1の 週次ボラティリティ は過去 1 年間で16%から11%に減少しましたが、依然としてGerman株の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイトn/an/an/amoreimpactag.deモア・インパクトAGは、再生可能エネルギー、栄養、ヘルスケア、電化産業への創造と資本市場に焦点を当てている。以前はAee Gold AGとして知られていたが、2024年4月にMore Impact AGに社名変更した。モア・インパクトAGはドイツのフランクフルト・アム・マインに本社を置いている。もっと見るMore Impact AG 基礎のまとめMore Impact の収益と売上を時価総額と比較するとどうか。AEE1 基礎統計学時価総額€237.53m収益（TTM）€0売上高(TTM)n/an/aPER（株価収益率n/aP/SレシオAEE1 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計AEE1 損益計算書（TTM）収益€0売上原価€0売上総利益€0その他の費用€0収益€0直近の収益報告該当なし次回決算日該当なし一株当たり利益（EPS）0グロス・マージン0.00%純利益率0.00%有利子負債／自己資本比率0.0%AEE1 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/28 02:37終値2026/06/26 00:00収益N/A年間収益N/Aデータソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋More Impact AG 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jun 26More Impact AG, Annual General Meeting, Aug 04, 2026More Impact AG, Annual General Meeting, Aug 04, 2026, at 11:00 W. Europe Standard Time.
New Risk • Dec 03New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (12% average weekly change). Shareholders have been substantially diluted in the past year (346% increase in shares outstanding).
お知らせ • Jul 15More Impact AG, Annual General Meeting, Aug 21, 2025More Impact AG, Annual General Meeting, Aug 21, 2025, at 11:00 W. Europe Standard Time.
お知らせ • Jul 02More Impact AG Announces Supervisory Board ChangesMore Impact AG announced that the Frankfurt District Court has appointed Prof. Dr. Stefan Hegemann as a new member of the Supervisory Board following a proposal by the company. He succeeds Dr. Karsten Behlke, who has resigned from office to move to the operational business of More Impact AG. Prof. Hegemann will stand for election to the Supervisory Board at the company's upcoming Ordinary General Meeting on August 21, 2025. With his long-standing experience as a medical doctor and his comprehensive scientific know-how, Prof. Hegemann will support More Impact in its future growth. He is a honorary professor of the University of Zurich and is also the founder of the renowned "Balance Clinic". Prof. Hegemann was head physician at the Department of Otorhinolaryngology and Facial Surgery of the University Hospital Zurich for several years. He also worked at the Johns Hopkins University in Baltimore and the Karlsbad-Langensteinbach Clinic. He completed his medical studies at the University of Essen, the LMU Munich, the McMaster University Hamilton and the University of Cape Town in South Africa. Prof. Hegemann is a member of the Prosper Menière Society, the Association of German-speaking Audiologists and Neurootologists (ADANO) and the Robert Barány Society. He is also a member of both the German Society for ENT and Neurology, Head and Neck Surgery and the Swiss Society for Otorhinolaryngology, Neck and Facial Surgery. In addition, he has been honoured with several accolades, including the ADANO Innovation Award.
New Risk • Apr 29New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €85.8m (US$97.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (14% average weekly change). Shareholders have been substantially diluted in the past year (over 8x increase in shares outstanding). Minor Risk Market cap is less than US$100m (€85.8m market cap, or US$97.9m).
お知らせ • Apr 10More Impact AG and BG Braingate Technology GmbH Introduces Z-Boxx as an Innovative Smoking Cessation ProductMore Impact AG and its wholly owned subsidiary BG Braingate Technology GmbH are launching the Z-Boxx. Braingate is thus integrating its patented inhaler technology into a marketable product. The Z-Boxx allows smokers to gradually quit nicotine without having to give up the smoking experience. The Z-Boxx thus makes an active contribution to improving health and also significantly reduces the burden on the environment by avoiding waste. The comprehensive market launch of the innovative product is planned for the fourth quarter of 2025. The Z-Boxx is based on an innovative, patented filter and vaporization technology that heats tobacco instead of burning it. The actual nicotine dosage can be regulated so that the Z-Boxx can be used to continuously reduce the smoker’s nicotine intake – right up to complete nicotine abstinence. In addition, no typical combustion products such as tar or carbon monoxide are produced. The mechanism of action of the Z-Boxx therefore directly addresses the most harmful aspects of smoking. Nevertheless, the smoking experience remains authentic in taste. Compared to disposable e-cigarettes or traditional tobacco products, the Z-Boxx produces no environmentally harmful filter waste, as filterless cigarettes are used and harmful substances are filtered out. According to the WHO, an estimated 4.5 trillion cigarette filters end up in the environment worldwide every year. The battery of the Z-Boxx can also be flexibly removed and recharged, which significantly reduces electronic waste.
お知らせ • Jun 26More Impact AG, Annual General Meeting, Aug 04, 2026More Impact AG, Annual General Meeting, Aug 04, 2026, at 11:00 W. Europe Standard Time.
New Risk • Dec 03New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (12% average weekly change). Shareholders have been substantially diluted in the past year (346% increase in shares outstanding).
お知らせ • Jul 15More Impact AG, Annual General Meeting, Aug 21, 2025More Impact AG, Annual General Meeting, Aug 21, 2025, at 11:00 W. Europe Standard Time.
お知らせ • Jul 02More Impact AG Announces Supervisory Board ChangesMore Impact AG announced that the Frankfurt District Court has appointed Prof. Dr. Stefan Hegemann as a new member of the Supervisory Board following a proposal by the company. He succeeds Dr. Karsten Behlke, who has resigned from office to move to the operational business of More Impact AG. Prof. Hegemann will stand for election to the Supervisory Board at the company's upcoming Ordinary General Meeting on August 21, 2025. With his long-standing experience as a medical doctor and his comprehensive scientific know-how, Prof. Hegemann will support More Impact in its future growth. He is a honorary professor of the University of Zurich and is also the founder of the renowned "Balance Clinic". Prof. Hegemann was head physician at the Department of Otorhinolaryngology and Facial Surgery of the University Hospital Zurich for several years. He also worked at the Johns Hopkins University in Baltimore and the Karlsbad-Langensteinbach Clinic. He completed his medical studies at the University of Essen, the LMU Munich, the McMaster University Hamilton and the University of Cape Town in South Africa. Prof. Hegemann is a member of the Prosper Menière Society, the Association of German-speaking Audiologists and Neurootologists (ADANO) and the Robert Barány Society. He is also a member of both the German Society for ENT and Neurology, Head and Neck Surgery and the Swiss Society for Otorhinolaryngology, Neck and Facial Surgery. In addition, he has been honoured with several accolades, including the ADANO Innovation Award.
New Risk • Apr 29New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €85.8m (US$97.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (14% average weekly change). Shareholders have been substantially diluted in the past year (over 8x increase in shares outstanding). Minor Risk Market cap is less than US$100m (€85.8m market cap, or US$97.9m).
お知らせ • Apr 10More Impact AG and BG Braingate Technology GmbH Introduces Z-Boxx as an Innovative Smoking Cessation ProductMore Impact AG and its wholly owned subsidiary BG Braingate Technology GmbH are launching the Z-Boxx. Braingate is thus integrating its patented inhaler technology into a marketable product. The Z-Boxx allows smokers to gradually quit nicotine without having to give up the smoking experience. The Z-Boxx thus makes an active contribution to improving health and also significantly reduces the burden on the environment by avoiding waste. The comprehensive market launch of the innovative product is planned for the fourth quarter of 2025. The Z-Boxx is based on an innovative, patented filter and vaporization technology that heats tobacco instead of burning it. The actual nicotine dosage can be regulated so that the Z-Boxx can be used to continuously reduce the smoker’s nicotine intake – right up to complete nicotine abstinence. In addition, no typical combustion products such as tar or carbon monoxide are produced. The mechanism of action of the Z-Boxx therefore directly addresses the most harmful aspects of smoking. Nevertheless, the smoking experience remains authentic in taste. Compared to disposable e-cigarettes or traditional tobacco products, the Z-Boxx produces no environmentally harmful filter waste, as filterless cigarettes are used and harmful substances are filtered out. According to the WHO, an estimated 4.5 trillion cigarette filters end up in the environment worldwide every year. The battery of the Z-Boxx can also be flexibly removed and recharged, which significantly reduces electronic waste.
New Risk • Mar 01New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €95.2m (US$98.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (25% average weekly change). Shareholders have been substantially diluted in the past year (over 8x increase in shares outstanding). Minor Risk Market cap is less than US$100m (€95.2m market cap, or US$98.7m).
New Risk • Sep 17New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Over 8x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Shareholders have been substantially diluted in the past year (over 8x increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Market cap is less than US$100m (€27.3m market cap, or US$30.4m).
New Risk • Aug 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Market cap is less than US$10m (€4.02m market cap, or US$4.40m). Minor Risk Share price has been volatile over the past 3 months (6.8% average weekly change).
お知らせ • Jul 23Aee Gold Ag, Annual General Meeting, Aug 29, 2024Aee Gold Ag, Annual General Meeting, Aug 29, 2024, at 11:00 W. Europe Standard Time.
